Kenvue, the company that makes Tylenol, is pushing back on the Trump administration’s claims that the widely used over-the-counter pain reliever is responsible for rising autism rates, saying no credible evidence links the drug to the neurodevelopmental condition.
The administration released its findings at a press conference on Monday showing a link between taking acetaminophen — the active ingredient in Tylenol — during pregnancy and an increased risk of the child developing autism.
“We believe independent, sound science clearly shows that taking acetaminophen does not cause autism,” a spokeswoman for Kenvue told the Daily Mail. “We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers.
Read more at Newsmax© 2025 Newsmax. All rights reserved.